Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Utah Medical Products, Inc. (NASDAQ: UTMD)
UTMD Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
4.40%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
UTMD Stock Analysis
UTMD
PE Ratio:
19.4
UTMD
PEG Ratio:
Not Available
UTMD
Forward EPS Growth (12 month):
0.00%
UTMD
PS Ratio:
5.6
UTMD
PSG Ratio:
Not Available
UTMD
Forward Revenue Growth (12 month):
0.00%
UTMD Articles
No data was found